An Open-Label Single-Arm, Phase Ii Trial of Zalutumumab, a Human Monoclonal Anti-Egfr Antibody, in Patients with Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck

AuthID
 P-009-HX5
7
Author(s)
Licitra, L
·
Dinis, J
·
Lisby, S
·
Document Type
Article
Year published
2014
Published
in CANCER CHEMOTHERAPY AND PHARMACOLOGY, ISSN: 0344-5704
Volume: 73, Issue: 6, Pages: 1227-1239 (13)
Indexing
Wos®
Scopus®
Crossref®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 24714973
SCOPUS: 2-s2.0-84903815444
Wos: WOS:000336395700015
Source Identifiers
ISSN: 0344-5704
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service